Neurological Implications of COVID-19 Infections

The magnitude of the COVID-19 pandemic will result in substantial neurological disease, whether through direct infection (rare), para-infectious complications (less rare), or critical illness more generally (common). Here, we raise the importance of stringent diagnosis and data collection regarding...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neurocritical care Jg. 32; H. 3; S. 667 - 671
Hauptverfasser:	Needham, Edward J., Chou, Sherry H.-Y., Coles, Alasdair J., Menon, David K.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	New York Springer US 01.06.2020 Springer Nature B.V
Schlagworte:	Betacoronavirus Biomarkers Brain research Cognitive Dysfunction - etiology Conflicts of interest Consent Coronavirus Infections - complications Coronavirus Infections - physiopathology COVID-19 Critical Care Critical Care Medicine Critical Illness Cross Infection - prevention & control Data Collection Disease Encephalitis Encephalomyelitis Encephalomyelitis, Acute Disseminated - etiology Epidemics Guillain-Barre syndrome Guillain-Barre Syndrome - etiology Humans Illnesses Immunosuppressive Agents - adverse effects Infection Control Infections Intensive Internal Medicine International Cooperation Longitudinal studies Medical laboratories Medicine Medicine & Public Health Mortality Myelitis, Transverse - etiology Nervous System Diseases - drug therapy Nervous System Diseases - etiology Nervous System Diseases - physiopathology Neurology Pandemics Pneumonia, Viral - complications Pneumonia, Viral - physiopathology SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Thromboembolism Viewpoint COVID-19 Encephalitis Guillain–Barré syndrome Acute disseminated encephalomyelitis
ISSN:	1541-6933, 1556-0961, 1556-0961
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The magnitude of the COVID-19 pandemic will result in substantial neurological disease, whether through direct infection (rare), para-infectious complications (less rare), or critical illness more generally (common). Here, we raise the importance of stringent diagnosis and data collection regarding neurological complications of COVID-19; we urge caution in the over-diagnosis of neurological disease where it does not exist, but equally strongly encourage the concerted surveillance for such conditions. Additional to the direct neurological complications of COVID-19 infection, neurological patients are at risk of harm from both structural limitations (such as number of intensive care beds), and a hesitancy to treat with certain necessary medications given risk of nosocomial COVID-19 infection. We therefore also outline the specific management of patients with neuroinflammatory diseases in the context of the pandemic. This article describes the implications of COVID-19 on neurological disease and advertises the Neurocritical Care Society’s international data collection collaborative that seeks to align data elements.
Bibliographie:	SourceType-Scholarly Journals-1 content type line 14 ObjectType-Editorial-2 ObjectType-Commentary-1 content type line 23
ISSN:	1541-6933 1556-0961 1556-0961
DOI:	10.1007/s12028-020-00978-4